Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain

Chia-Chen Liu, Jin Hu, Chih Wei Tsai, Mei Yue, Heather L Melrose, Takahisa Kanekiyo, Guojun D Bu

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Alzheimer’s disease (AD) is a neurological disorder characterized by profound memory loss and progressive dementia. Accumulating evidence suggests that Type 2 diabetes mellitus, a metabolic disorder characterized by insulin resistance and glucose intolerance, significantly increases the risk for developing AD. Whereas amyloid-β (Aβ) deposition and neurofibrillary tangles are major histological hallmarks of AD, impairment of cerebral glucose metabolism precedes these pathological changes during the early stage of AD and likely triggers or exacerbates AD pathology. However, the mechanisms linking disturbed insulin signaling/glucose metabolism and AD pathogenesis remain unclear. The low-density lipoprotein receptor-related protein 1 (LRP1), a major apolipoprotein E receptor, plays critical roles in lipoprotein metabolism, synaptic maintenance, and clearance of Aβ in the brain. Here, we demonstrate that LRP1 interacts with the insulin receptor β in the brain and regulates insulin signaling and glucose uptake. LRP1 deficiency in neurons leads to impaired insulin signaling as well as reduced levels of glucose transporters GLUT3 and GLUT4. Consequently, glucose uptake is reduced. By using an in vivo microdialysis technique sampling brain glucose concentration in freely moving mice, we further show that LRP1 deficiency in conditional knock-out mice resulted in glucose intolerance in the brain. We also found that hyperglycemia suppresses LRP1 expression, which further exacerbates insulin resistance, glucose intolerance, and AD pathology. As loss of LRP1 expression is seen in AD brains, our study provides novel insights into insulin resistance in AD. Our work also establishes new targets that can be explored for AD prevention or therapy.

Original languageEnglish (US)
Pages (from-to)5851-5859
Number of pages9
JournalJournal of Neuroscience
Volume35
Issue number14
DOIs
StatePublished - Apr 8 2015

Fingerprint

Lipoprotein Receptors
Alzheimer Disease
Insulin
Glucose
Brain
Proteins
Glucose Intolerance
Low Density Lipoprotein Receptor-Related Protein-1
Insulin Resistance
Protein Deficiency
Pathology
Neurofibrillary Tangles
Facilitative Glucose Transport Proteins
Insulin Receptor
Microdialysis
Memory Disorders
Nervous System Diseases
Amyloid
Knockout Mice
Hyperglycemia

Keywords

  • Alzheimer’s disease
  • Apolipoprotein e
  • Glucose metabolism
  • Insulin signaling
  • LRP1

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain. / Liu, Chia-Chen; Hu, Jin; Tsai, Chih Wei; Yue, Mei; Melrose, Heather L; Kanekiyo, Takahisa; Bu, Guojun D.

In: Journal of Neuroscience, Vol. 35, No. 14, 08.04.2015, p. 5851-5859.

Research output: Contribution to journalArticle

Liu, Chia-Chen ; Hu, Jin ; Tsai, Chih Wei ; Yue, Mei ; Melrose, Heather L ; Kanekiyo, Takahisa ; Bu, Guojun D. / Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain. In: Journal of Neuroscience. 2015 ; Vol. 35, No. 14. pp. 5851-5859.
@article{9f29aabb31a94008b875c9e6a82dbf82,
title = "Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain",
abstract = "Alzheimer’s disease (AD) is a neurological disorder characterized by profound memory loss and progressive dementia. Accumulating evidence suggests that Type 2 diabetes mellitus, a metabolic disorder characterized by insulin resistance and glucose intolerance, significantly increases the risk for developing AD. Whereas amyloid-β (Aβ) deposition and neurofibrillary tangles are major histological hallmarks of AD, impairment of cerebral glucose metabolism precedes these pathological changes during the early stage of AD and likely triggers or exacerbates AD pathology. However, the mechanisms linking disturbed insulin signaling/glucose metabolism and AD pathogenesis remain unclear. The low-density lipoprotein receptor-related protein 1 (LRP1), a major apolipoprotein E receptor, plays critical roles in lipoprotein metabolism, synaptic maintenance, and clearance of Aβ in the brain. Here, we demonstrate that LRP1 interacts with the insulin receptor β in the brain and regulates insulin signaling and glucose uptake. LRP1 deficiency in neurons leads to impaired insulin signaling as well as reduced levels of glucose transporters GLUT3 and GLUT4. Consequently, glucose uptake is reduced. By using an in vivo microdialysis technique sampling brain glucose concentration in freely moving mice, we further show that LRP1 deficiency in conditional knock-out mice resulted in glucose intolerance in the brain. We also found that hyperglycemia suppresses LRP1 expression, which further exacerbates insulin resistance, glucose intolerance, and AD pathology. As loss of LRP1 expression is seen in AD brains, our study provides novel insights into insulin resistance in AD. Our work also establishes new targets that can be explored for AD prevention or therapy.",
keywords = "Alzheimer’s disease, Apolipoprotein e, Glucose metabolism, Insulin signaling, LRP1",
author = "Chia-Chen Liu and Jin Hu and Tsai, {Chih Wei} and Mei Yue and Melrose, {Heather L} and Takahisa Kanekiyo and Bu, {Guojun D}",
year = "2015",
month = "4",
day = "8",
doi = "10.1523/JNEUROSCI.5180-14.2015",
language = "English (US)",
volume = "35",
pages = "5851--5859",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "14",

}

TY - JOUR

T1 - Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain

AU - Liu, Chia-Chen

AU - Hu, Jin

AU - Tsai, Chih Wei

AU - Yue, Mei

AU - Melrose, Heather L

AU - Kanekiyo, Takahisa

AU - Bu, Guojun D

PY - 2015/4/8

Y1 - 2015/4/8

N2 - Alzheimer’s disease (AD) is a neurological disorder characterized by profound memory loss and progressive dementia. Accumulating evidence suggests that Type 2 diabetes mellitus, a metabolic disorder characterized by insulin resistance and glucose intolerance, significantly increases the risk for developing AD. Whereas amyloid-β (Aβ) deposition and neurofibrillary tangles are major histological hallmarks of AD, impairment of cerebral glucose metabolism precedes these pathological changes during the early stage of AD and likely triggers or exacerbates AD pathology. However, the mechanisms linking disturbed insulin signaling/glucose metabolism and AD pathogenesis remain unclear. The low-density lipoprotein receptor-related protein 1 (LRP1), a major apolipoprotein E receptor, plays critical roles in lipoprotein metabolism, synaptic maintenance, and clearance of Aβ in the brain. Here, we demonstrate that LRP1 interacts with the insulin receptor β in the brain and regulates insulin signaling and glucose uptake. LRP1 deficiency in neurons leads to impaired insulin signaling as well as reduced levels of glucose transporters GLUT3 and GLUT4. Consequently, glucose uptake is reduced. By using an in vivo microdialysis technique sampling brain glucose concentration in freely moving mice, we further show that LRP1 deficiency in conditional knock-out mice resulted in glucose intolerance in the brain. We also found that hyperglycemia suppresses LRP1 expression, which further exacerbates insulin resistance, glucose intolerance, and AD pathology. As loss of LRP1 expression is seen in AD brains, our study provides novel insights into insulin resistance in AD. Our work also establishes new targets that can be explored for AD prevention or therapy.

AB - Alzheimer’s disease (AD) is a neurological disorder characterized by profound memory loss and progressive dementia. Accumulating evidence suggests that Type 2 diabetes mellitus, a metabolic disorder characterized by insulin resistance and glucose intolerance, significantly increases the risk for developing AD. Whereas amyloid-β (Aβ) deposition and neurofibrillary tangles are major histological hallmarks of AD, impairment of cerebral glucose metabolism precedes these pathological changes during the early stage of AD and likely triggers or exacerbates AD pathology. However, the mechanisms linking disturbed insulin signaling/glucose metabolism and AD pathogenesis remain unclear. The low-density lipoprotein receptor-related protein 1 (LRP1), a major apolipoprotein E receptor, plays critical roles in lipoprotein metabolism, synaptic maintenance, and clearance of Aβ in the brain. Here, we demonstrate that LRP1 interacts with the insulin receptor β in the brain and regulates insulin signaling and glucose uptake. LRP1 deficiency in neurons leads to impaired insulin signaling as well as reduced levels of glucose transporters GLUT3 and GLUT4. Consequently, glucose uptake is reduced. By using an in vivo microdialysis technique sampling brain glucose concentration in freely moving mice, we further show that LRP1 deficiency in conditional knock-out mice resulted in glucose intolerance in the brain. We also found that hyperglycemia suppresses LRP1 expression, which further exacerbates insulin resistance, glucose intolerance, and AD pathology. As loss of LRP1 expression is seen in AD brains, our study provides novel insights into insulin resistance in AD. Our work also establishes new targets that can be explored for AD prevention or therapy.

KW - Alzheimer’s disease

KW - Apolipoprotein e

KW - Glucose metabolism

KW - Insulin signaling

KW - LRP1

UR - http://www.scopus.com/inward/record.url?scp=84929380062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929380062&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.5180-14.2015

DO - 10.1523/JNEUROSCI.5180-14.2015

M3 - Article

C2 - 25855193

AN - SCOPUS:84929380062

VL - 35

SP - 5851

EP - 5859

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 14

ER -